p53, p16 and Fhit Proteins Expressions in Chronic Esophagitis and Chagas Disease

被引:0
|
作者
Bellini, Marilanda Ferreira
Leite, Katia Ramos Moreira [2 ]
Cury, Patricia Maluf [3 ]
Silva, Ana Elizabete [1 ]
机构
[1] UNESP, IBILCE, Dept Biol, BR-15054000 Sao Jose Dos Campos, SP, Brazil
[2] Hosp Sirio Libanes, Lab Surg & Mol Pathol, Sao Paulo, Brazil
[3] FAMERP Med Sch, Dept Pathol, Sao Jose Dos Campos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
p53; p16; Fhit protein; esophagitis; megaesophagus; esophageal carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Models have suggested esophageal carcinogenesis can result front the alteration of sequences, leading to esophagitis, atrophy, dysplasia, carcinoma in situ and invasive carcinoma. While numerous genetic alterations have been reported in esophageal carcinogenesis, studies of benign lesions with precancerous potential are scarce. Materials and Methods: Immunohistochemistry was performed for p53, p16 and Fhit proteins in the esophageal mucosa from patients with Chagas disease (CD), chagasic megaesophagus (CM), chronic esophagitis (CE), esophageal squamous cell carcinoma (ESCC) and in normal mucosa (NM). Results: The proportion of p53-positive cases increased progressively according to the severity of the pathology CD (7.7%), CM (26.1%), CE (52.2%) and ESCC (100%). However, p16 and Fhit did not show any statistically significant differences among the groups. Conclusion: p53 overexpression is involved in the initial steps of esophageal carcinogenesis, supporting further evaluation of its utility as a marker in precursor lesions, conversely, losses of Fhit and p16 expression may not be significant.
引用
收藏
页码:3793 / 3799
页数:7
相关论文
共 50 条
  • [1] Immunohistochemical expressions of p16 and p53 proteins in cervical intraepithelial neoplasia and in benign cervical tissue
    Tosun, G.
    Sendag, F.
    Zeybek, B.
    Terek, M. Cosan
    Guven, C.
    Zekiogly, O.
    Bilgin, O.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (06) : 627 - 631
  • [2] Immunohistochemistry of p16 and p53 in vulvar cancer
    Florencia Falcon, Maria
    Eugenia Paradeda, Maria
    Garcia Kamermann, Florencia
    Maldonado, Veronica
    Diaz, Lili
    Cardinal, Lucia
    MEDICINA-BUENOS AIRES, 2020, 80 (02) : 127 - 133
  • [3] EXPRESSION OF p16 AND p53 IN GASTRIC CARCINOMA
    Ma Yu Gao Liping Song Yifeng Jing Jiong Wang ChunjiangFirst Department of SurgeryShengzhou Peoples Hospital Shengzhou
    中国现代医学杂志, 2003, (01) : 30 - 33+39
  • [4] Immunohistochemistry of P16 and P53 in vulvar cancer
    Lewkowicz, M. D. L. M.
    Paradeda, M. E.
    Gomez Cherey, F.
    Falcon, M. F.
    Garcia Kammermann, F.
    Sciaccaluga, D.
    Maldonado, V.
    Palaoro, L.
    Diaz, L.
    Cardinal, L.
    VIRCHOWS ARCHIV, 2020, 477 : S68 - S69
  • [5] P53 and P16 alterations in lung cancer
    Niklinski, J
    Niklinska, W
    Chyczewski, L
    Chyczewska, E
    Laudanski, J
    ENDOCRINE DISRUPTERS AND CARCINOGENIC RISK ASSESSMENT, 2002, 340 : 178 - 187
  • [6] Infrequent genetic alterations of p53, p16 genes and polymorphism in fhit gene in Indian myelodysplastic syndrome
    Kannan, K
    Tharu, R
    Gopinath, PM
    Bharadwaj, TPR
    Munirajan, AK
    Tsuchida, N
    Shanmugam, G
    ONCOLOGY RESEARCH, 1999, 11 (02) : 101 - 104
  • [7] Expression of FHIT, p16, p53 and EGFR as prognostic markers in thyroid tumors of uncertain malignant potential
    Koc, Mustafa
    Aktimur, Recep
    Gokakin, Ali Kagan
    Atabey, Mustafa
    Koyuncu, Ayhan
    Elagoz, Sahende
    Topcu, Omer
    JOURNAL OF BUON, 2015, 20 (02): : 567 - 572
  • [8] PROGNOSTIC AFFECT OF P16 AND P53 EXPRESSIONS ON STAGE 1A EPITHELIAL OVARIAN CANCER
    Ayhan, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [9] Immunohistochemical analysis of P53 and P16 in pancreatic carcinoma
    Goitia-Duran, M.
    Artigiani-Neto, R.
    Linhares, M.
    Goldenberg, A.
    HISTOPATHOLOGY, 2008, 53 : 135 - 136
  • [10] Coexpression of p53 and p16 in Vulvar Squamous Neoplasia
    Jeffus, Susanne K.
    Quick, Charles M.
    MODERN PATHOLOGY, 2023, 36 (10)